Stablepharma and SmartBio Analytics have been recognised for their contribution to scientific development, biomedical innovation and improved access to treatments.
The innovation being developed at Qube Technology Park has once again received significant recognition. Two of the companies based at the technology park, Stablepharma and SmartBio Analytics, were honoured at the 2026 Ciudad de Tres Cantos Business Awards Gala, organised by the Tres Cantos Business Association (AETC), the Tres Cantos Association of Companies, Retailers and Self-Employed Professionals (ASECATC), and the Tres Cantos-based agency Comunicatrik.
Stablepharma received the Solidarity Award for the social impact of its technology, which is focused on improving access to medicines and vaccines. The company develops solutions that allow pharmaceutical products to be stored without the need for cold chain logistics, an innovation with the potential to facilitate access to treatments worldwide and reduce waste associated with the transport and storage of medicines.
SmartBio Analytics, meanwhile, was recognised with the Business Innovation Award for its contribution to scientific progress and the development of new medicines. The company, which specialises in bioanalytical services for the pharmaceutical and biotechnology industries, has established itself as a leading player in the sector and was a pioneer in becoming the first bioanalytical laboratory in the Community of Madrid to be certified in Good Laboratory Practice (GLP) for regulated studies.
Although they operate in different areas, both companies share the same vision: to use science and innovation to address some of the major challenges in global health.
These awards highlight the ability of companies based at Qube Technology Park to generate high-value innovation and transform scientific knowledge into solutions with a real impact on society.
The presence of Stablepharma and SmartBio Analytics among the award-winning companies reinforces Qube Technology Park’s role as one of the leading ecosystems for innovation, research and technological development in the Community of Madrid, consolidating Tres Cantos as a national benchmark in science, biotechnology and health.
